Adhera Therapeutics, Inc. (ATRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST
Adhera Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2015 |
| Revenue | - | - | - | - | 0.25 | 0.08 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | 231.58% | - | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.41 | 0.28 | Upgrade
|
| Gross Profit | - | - | - | - | -0.16 | -0.21 | Upgrade
|
| Selling, General & Admin | 1.28 | 1.62 | 0.67 | 2.04 | 9.97 | 9.84 | Upgrade
|
| Research & Development | - | - | - | - | - | 0.24 | Upgrade
|
| Operating Expenses | 1.28 | 1.62 | 0.67 | 2.04 | 10.04 | 10.41 | Upgrade
|
| Operating Income | -1.28 | -1.62 | -0.67 | -2.04 | -10.2 | -10.62 | Upgrade
|
| Interest Expense | -3.19 | -3.15 | -1.43 | -1.77 | -0.66 | -0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.13 | 2.32 | -4.1 | 0.05 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -4.6 | -2.45 | -6.21 | -3.77 | -10.86 | -10.77 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -3.5 | Upgrade
|
| Asset Writedown | - | - | - | - | -1.12 | -1.68 | Upgrade
|
| Other Unusual Items | 0.11 | 0.33 | -0.14 | - | - | -0.81 | Upgrade
|
| Pretax Income | -4.49 | -2.11 | -6.35 | -3.77 | -11.98 | -16.76 | Upgrade
|
| Net Income | -4.49 | -2.11 | -6.35 | -3.77 | -11.98 | -16.76 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.13 | 0.62 | 2.05 | 1.54 | 1.5 | 1.06 | Upgrade
|
| Net Income to Common | -4.61 | -2.73 | -8.41 | -5.31 | -13.48 | -17.82 | Upgrade
|
| Shares Outstanding (Basic) | 4 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 104.10% | 252.46% | 20.39% | 0.33% | 0.02% | 10.19% | Upgrade
|
| EPS (Basic) | -1.31 | -1.18 | -12.84 | -9.76 | -24.87 | -32.88 | Upgrade
|
| EPS (Diluted) | -1.31 | -1.18 | -12.84 | -9.76 | -24.87 | -32.88 | Upgrade
|
| Free Cash Flow | -0.71 | -1.42 | -0.67 | -0.59 | -8.74 | -9.69 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.61 | -1.02 | -1.08 | -16.12 | -17.87 | Upgrade
|
| Gross Margin | - | - | - | - | -62.30% | -273.68% | Upgrade
|
| Operating Margin | - | - | - | - | -4047.62% | -13972.37% | Upgrade
|
| Profit Margin | - | - | - | - | -5348.81% | -23446.05% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -3467.46% | -12743.42% | Upgrade
|
| EBITDA | - | - | - | -1.96 | -10.12 | -10.29 | Upgrade
|
| D&A For EBITDA | - | - | - | 0.08 | 0.08 | 0.33 | Upgrade
|
| EBIT | -1.28 | -1.62 | -0.67 | -2.04 | -10.2 | -10.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.